 | Up a level |
Karamitopoulou, Eva; Wenning, Anna Silvia; Acharjee, Animesh; Zlobec, Inti; Aeschbacher, Pauline; Perren, Aurel; Gloor, Beat (2023). Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancer. Gut, 72(8), pp. 1523-1533. BMJ Publishing Group 10.1136/gutjnl-2022-329371
Ferguson, L Paige; Gatchalian, Jovylyn; McDermott, Matthew L; Nakamura, Mari; Chambers, Kendall; Rajbhandari, Nirakar; Lytle, Nikki K; Rosenthal, Sara Brin; Hamilton, Michael; Albini, Sonia; Wartenberg, Martin; Zlobec, Inti; Galván Hernández, José Alberto; Karamitopoulou, Eva; Vavinskaya, Vera; Wascher, Alexis; Lowy, Andrew M; Schürch, Christian M; Puri, Pier Lorenzo; Bruneau, Benoit G; ... (2023). Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma. Nature Communications, 14(1), p. 292. Springer Nature 10.1038/s41467-023-35796-7
Karamitopoulou, Evanthia; Wartenberg, Martin; Zlobec, Inti; Cibin, Silvia; Worni, Mathias; Gloor, Beat; Lugli, Alessandro (2018). Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system. Histopathology, 73(1), pp. 137-146. Wiley 10.1111/his.13508
